253 related articles for article (PubMed ID: 15557198)
1. Inhibition of fractalkine ameliorates murine collagen-induced arthritis.
Nanki T; Urasaki Y; Imai T; Nishimura M; Muramoto K; Kubota T; Miyasaka N
J Immunol; 2004 Dec; 173(11):7010-6. PubMed ID: 15557198
[TBL] [Abstract][Full Text] [Related]
2. Role of Anti-Fractalkine Antibody in Suppression of Joint Destruction by Inhibiting Migration of Osteoclast Precursors to the Synovium in Experimental Arthritis.
Hoshino-Negishi K; Ohkuro M; Nakatani T; Kuboi Y; Nishimura M; Ida Y; Kakuta J; Hamaguchi A; Kumai M; Kamisako T; Sugiyama F; Ikeda W; Ishii N; Yasuda N; Imai T
Arthritis Rheumatol; 2019 Feb; 71(2):222-231. PubMed ID: 30079992
[TBL] [Abstract][Full Text] [Related]
3. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis.
Ruth JH; Volin MV; Haines GK; Woodruff DC; Katschke KJ; Woods JM; Park CC; Morel JC; Koch AE
Arthritis Rheum; 2001 Jul; 44(7):1568-81. PubMed ID: 11465708
[TBL] [Abstract][Full Text] [Related]
4. Recruitment of CD16+ monocytes into synovial tissues is mediated by fractalkine and CX3CR1 in rheumatoid arthritis patients.
Yano R; Yamamura M; Sunahori K; Takasugi K; Yamana J; Kawashima M; Makino H
Acta Med Okayama; 2007 Apr; 61(2):89-98. PubMed ID: 17471309
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of CX3CL1 (fractalkine) improves experimental autoimmune myositis in SJL/J mice.
Suzuki F; Nanki T; Imai T; Kikuchi H; Hirohata S; Kohsaka H; Miyasaka N
J Immunol; 2005 Nov; 175(10):6987-96. PubMed ID: 16272359
[TBL] [Abstract][Full Text] [Related]
6. T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis.
Sawai H; Park YW; Roberson J; Imai T; Goronzy JJ; Weyand CM
Arthritis Rheum; 2005 May; 52(5):1392-401. PubMed ID: 15880821
[TBL] [Abstract][Full Text] [Related]
7. Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis.
Nanki T; Imai T; Nagasaka K; Urasaki Y; Nonomura Y; Taniguchi K; Hayashida K; Hasegawa J; Yoshie O; Miyasaka N
Arthritis Rheum; 2002 Nov; 46(11):2878-83. PubMed ID: 12428227
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis.
Nanki T; Shimaoka T; Hayashida K; Taniguchi K; Yonehara S; Miyasaka N
Arthritis Rheum; 2005 Oct; 52(10):3004-14. PubMed ID: 16200580
[TBL] [Abstract][Full Text] [Related]
9. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice.
Inoue A; Hasegawa H; Kohno M; Ito MR; Terada M; Imai T; Yoshie O; Nose M; Fujita S
Arthritis Rheum; 2005 May; 52(5):1522-33. PubMed ID: 15880599
[TBL] [Abstract][Full Text] [Related]
10. Fractalkine is a novel chemoattractant for rheumatoid arthritis fibroblast-like synoviocyte signaling through MAP kinases and Akt.
Volin MV; Huynh N; Klosowska K; Chong KK; Woods JM
Arthritis Rheum; 2007 Aug; 56(8):2512-22. PubMed ID: 17665439
[TBL] [Abstract][Full Text] [Related]
11. Fractalkine mediates T cell-dependent proliferation of synovial fibroblasts in rheumatoid arthritis.
Sawai H; Park YW; He X; Goronzy JJ; Weyand CM
Arthritis Rheum; 2007 Oct; 56(10):3215-25. PubMed ID: 17907166
[TBL] [Abstract][Full Text] [Related]
12. Blockade of the fractalkine-CX3CR1 axis ameliorates experimental colitis by dislodging venous crawling monocytes.
Kuboi Y; Nishimura M; Ikeda W; Nakatani T; Seki Y; Yamaura Y; Ogawa K; Hamaguchi A; Muramoto K; Mizuno K; Ogasawara H; Yamauchi T; Yasuda N; Onodera H; Imai T
Int Immunol; 2019 Apr; 31(5):287-302. PubMed ID: 30668715
[TBL] [Abstract][Full Text] [Related]
13. A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection.
Robinson LA; Nataraj C; Thomas DW; Howell DN; Griffiths R; Bautch V; Patel DD; Feng L; Coffman TM
J Immunol; 2000 Dec; 165(11):6067-72. PubMed ID: 11086038
[TBL] [Abstract][Full Text] [Related]
14. Depletion of collagen II-reactive T cells and blocking of B cell activation prevents collagen II-induced arthritis in DBA/1j mice.
Zhang HG; Yang P; Xie J; Liu Z; Liu D; Xiu L; Zhou T; Wang Y; Hsu HC; Mountz JD
J Immunol; 2002 Apr; 168(8):4164-72. PubMed ID: 11937577
[TBL] [Abstract][Full Text] [Related]
15. Proinflammatory role of fractalkine (CX3CL1) in rheumatoid arthritis.
Blaschke S; Koziolek M; Schwarz A; Benöhr P; Middel P; Schwarz G; Hummel KM; Müller GA
J Rheumatol; 2003 Sep; 30(9):1918-27. PubMed ID: 12966591
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation.
Iwai H; Kozono Y; Hirose S; Akiba H; Yagita H; Okumura K; Kohsaka H; Miyasaka N; Azuma M
J Immunol; 2002 Oct; 169(8):4332-9. PubMed ID: 12370365
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors.
Nukiwa M; Andarini S; Zaini J; Xin H; Kanehira M; Suzuki T; Fukuhara T; Mizuguchi H; Hayakawa T; Saijo Y; Nukiwa T; Kikuchi T
Eur J Immunol; 2006 Apr; 36(4):1019-27. PubMed ID: 16525992
[TBL] [Abstract][Full Text] [Related]
18. Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease.
Sans M; Danese S; de la Motte C; de Souza HS; Rivera-Reyes BM; West GA; Phillips M; Katz JA; Fiocchi C
Gastroenterology; 2007 Jan; 132(1):139-53. PubMed ID: 17241867
[TBL] [Abstract][Full Text] [Related]
19. Tracking of proinflammatory collagen-specific T cells in early and late collagen-induced arthritis in humanized mice.
Svendsen P; Andersen CB; Willcox N; Coyle AJ; Holmdahl R; Kamradt T; Fugger L
J Immunol; 2004 Dec; 173(11):7037-45. PubMed ID: 15557201
[TBL] [Abstract][Full Text] [Related]
20. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses.
Fraticelli P; Sironi M; Bianchi G; D'Ambrosio D; Albanesi C; Stoppacciaro A; Chieppa M; Allavena P; Ruco L; Girolomoni G; Sinigaglia F; Vecchi A; Mantovani A
J Clin Invest; 2001 May; 107(9):1173-81. PubMed ID: 11342581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]